Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00282113 · ClinicalTrials.gov registry record · NA
Effects of Probiotic and Prebiotic Combinations on Premature Infants
A NA study, sponsored by University of California, Davis.
- Completed
- Registry status
- NA
- Development phase
- 90
- Enrollment target
NCT00282113 is a NA study that has completed, run by University of California, Davis. The registered enrollment target is 90 participants.
The verdict
NCT00282113, a NA study, has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
Study Summary
The purpose of this study is to see how oral preparations containing both probiotics and prebiotics impact the growth, bacterial colonization of the intestines, and fecal short chain fatty acid content in premature infants. Our hypothesis is that short term growth will be improved, the stool will have more healthy bacteria, and the fecal short chain fatty acid content will increase in the babies who receive the probiotic/prebiotic combinations compared to control groups.
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT ProBioPlus
- DIETARY_SUPPLEMENT Culturelle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2004-10 |
| Est. Completion | 2007-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00282113
The ClinicalTrials.gov registry entry for NCT00282113 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT00282113 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00282113 about?
NCT00282113 is a clinical study titled "Effects of Probiotic and Prebiotic Combinations on Premature Infants". The purpose of this study is to see how oral preparations containing both probiotics and prebiotics impact the growth, bacterial colonization of the intestines, and fecal short chain fatty acid content in premature infants. Our hypothesis is that short term growth will be improved, the stool will ha...
What is the current status of trial NCT00282113?
This trial is currently completed. It is a NA study. The enrollment target is 90 participants. The study started on 2004-10. Estimated completion is 2007-08.
What interventions are being tested in trial NCT00282113?
The interventions under investigation include: Placebo (OTHER), ProBioPlus (DIETARY_SUPPLEMENT), Culturelle (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00282113?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.